EVALUATION OF THE CLINICAL COURSE OF MYOCARDITIS AND MYOPERICARDITIS IN PATIENTS WITH COVID-19

AKHMEDOVA Gulchekhra Abdullayevna, SHUKHUROVA Dilorom Baxodirovna

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2025-yil

Annotatsiya

In December 2019, a new respiratory infection caused by a previously unidentified strain of coronavirus, named SARS-CoV-2, was identified in China. This virus belongs to the Coronaviridae family, Nidovirales, and is characterized by a pleomorphic structure with crown-like spikes on its surface, which is why it was named "coronavirus". The size of the viral particles varies from 80 to 160 nanometers, and the genome length, expressed as positive-sense RNA, ranges from 27 to 32 kilobases. The emergence of SARS-CoV-2 led to a global pandemic, named COVID-19.

Maqola ma’lumotlari
MualliflarAKHMEDOVA Gulchekhra Abdullayevna, SHUKHUROVA Dilorom Baxodirovna
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2025-10-31
Jild10
Son4
TilO‘zbek

Kalit so‘zlar

коронавирусная болезнь 2019, вирус тяжелого острого респираторного синдрома, скорость оседания эритроцитов, С-реактивный белок, аспартатаминотрансфераза, coronavirus disease 2019, severe acute respiratory syndrome virus, erythrocyte sedimentation rate, C-reactive protein, aspartate aminotransferase, коронавирус касаллиги 2019, оғир ўткир респиратор синдром вируси, эритроцитларнинг чўкиш тезлиги, C-реактив оқсил, аспартат аминотрансфераза

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar